Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD

1.500

-0.150 (-9.09%)

At close: May 10, 2024, 4:00 PM

1.520

+0.020 (1.33%)

After-hours: May 10, 2024, 7:26 PM EDT

Adial Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-5.12	-12.73	-19.42	-10.89	-8.59	-11.63	-1.14	-0.42
Depreciation & Amortization	0	0	0.06	0	0	0	0	0
Share-Based Compensation	1.75	3.37	4.24	2.01	1.6	5.37	0.21	0.15
Other Operating Activities	-3.43	-1.83	3.18	1.25	0.65	3.76	0.44	-0.01
Operating Cash Flow	-6.81	-11.19	-11.95	-7.63	-6.34	-2.5	-0.49	-0.27
Capital Expenditures	0	0	-0.06	0	0	0	0	0
Acquisitions	1.5	0	0.03	-0.35	0	0	0	0
Change in Investments	0	0	0	0	0	0	0.04	0
Investing Cash Flow	1.5	0	-0.03	-0.35	0	0	0.04	0
Share Issuance / Repurchase	0.75	9.13	13.64	5.61	9.25	6.27	0.04	0
Debt Issued / Paid	0	0	0	0	0	-0.08	0.35	0.2
Other Financing Activities	3.38	-	-	-	-	0.16	-	-
Financing Cash Flow	4.13	9.13	13.64	5.61	9.25	6.35	0.39	0.2
Net Cash Flow	-1.17	-2.06	1.66	-2.38	2.91	3.85	-0.07	-0.07
Free Cash Flow	-6.81	-11.19	-12.01	-7.63	-6.34	-2.5	-0.49	-0.27
Free Cash Flow Per Share	-4.78	-11.17	-16.16	-15.31	-16.08	-13.12	-3.79	-2.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).